Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: Results of a pilot study

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 6, 1998, Pages 477-481

  McTiernan, Anne ^a,b   Ulrich, Cornelia ^a,b   Kumai, Claudia ^a   Bean, Deanna ^a   Schwartz, Robert ^c   Mahloch, Jan ^a   Hastings, Rob ^c   Gralow, Julie ^c   Potter, John D ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BODY FAT; BREAST CANCER; CALORIC RESTRICTION; CANCER STAGING; COMORBIDITY; ESTROGEN BLOOD LEVEL; EXERCISE; FEMALE; HUMAN; LOW FAT DIET; MAJOR CLINICAL STUDY; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; AGED; BREAST NEOPLASMS; DIET, FAT-RESTRICTED; EXERCISE; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; OBESITY; PILOT PROJECTS;

EID: 0031903631     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Kelsey, J. L., and Horn-Ross, P. L. Breast cancer, magnitude of the problem and descriptive epidemiology, Epidemiol Rev., 15: 7-16, 1993.
2. Zelen, M , and Gelman, R. Assessment of adjuvant trials in breast cancer NCI Monogr., 1: 11-17, 1986.
3. Schapira, D., Kumar, N. B., Lyman, G. H., and Cox, C E Obesity and body fat distribution and breast cancer prognosis. Cancer (Phila ), 61: 523-528, 1991
4. Lonning, P. E., Helle, S. I., Johannessen, D. C., Ekse, K., and Adlercreutz, H. Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer. Breast Cancer Res Treat., 39: 335-341, 1996
5. Toniolo, P , Levitz, M , Jacquotte, A., Koenig, K , Shore, R., and Pasternack, B. A prospective study of endogenous estrogens and breast cancer in postmenopausal women J. Natl. Cancer Inst. (Bethesda), 87, 190-197, 1995
6. Dorgan, J F., Longcope, C., Staphenson, H. E., Falk, R. T , Miller, R., Franz, C., Kahle, L , Campbell, W S., Tangra, J A., and Schatzken, A. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk. Cancer Epidemiol. Biomark. Prev , 5: 533-539, 1996.
7. Siiteri, P K., Murai, J. T., Hammond, G. L , Nisker, J. A , Ramoure, W J , and Kuhn, R W. The serum transport of steroid hormones. Rec Prog Horm. Res., 38: 457-510, 1982.
8. Bruning, P F., Bonfrer, J. M G., van Noord, P A. H , deJong Bakker, M., and Nooijen, W. J. Insulin resistance and breast cancer risk Int. J. Cancer, 52: 511-516, 1992.
9. Bruce, G., Hartman, A. M., Presser, C. M , Carroll, M O., Gannon, J , and Hardner, L. A data-based approach to diet questionnaire design and testing Am. J Epidemiol., 124: 453-469, 1986.
10. Vitiello, M V., Wilkinson, C W., Merriam, G. R , Moe, K. E., Prinz, P. N., Ralph, D. D , Colsurdo, E. A., and Schwartz, R. S. Successful 6-month endurance training does not alter insulin-like growth factor 1 in healthy older men and women J Gerontol. A Biol Sci Med. Sci , 52: 149-154, 1997
11. Tinker, L. F., Burrows, E R , Henry, H., Patterson, R., Rupp. J , and Van Horn, L. The Women's Health Initiative: overview of the nutrition components In: D. Krummel and P. Kris-Etherton (eds ), Nutrition and Women's Health, pp 510-542. Gaithersburg, MD: Aspen Publishers, 1996.
12. Senie, R. T , Rosen, P P., Rhodes, P , Lesser, M. L., and Kinne, D. W. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival Ann Intern Med , 116, 26-32, 1992
13. Tornberg, S , and Carstensen, J. Serum β-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients. Eur J. Cancer, 29A: 2025-2030, 1993.
14. Jain, M , and Miller, A B. Pre-morbid body size and the prognosis of women with breast cancer. Int. J. Cancer. 59: 363-368, 1994
15. Newman, S. C., Lees, A W , and Jenkins, H. J The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int. J Epidemiol., 26: 484-490, 1997.
16. World Cancer Research Fund Panel Food, Nutrition and the Prevention of Cancer A Global Perspective, pp 78-79. Washington, DC: American Institute for Cancer Research, 1997.
17. McTiernan, A , Stanford, J., Daling, J. and Voigt, L Prevalence and correlates of physical activity in middle aged women. Menopause, in press, 1998.
18. Patterson, R E , Neuhouser, M. L., White, E., Hunt, J. R., and Kristal, A R. Cancer-related behavior of vitamin supplement users Cancer Epidemiol. Biomark. Prev., 7: 79-81, 1998.
19. Prentice, R. L. Measurement error and results from analytic epidemiology dietary fat and breast cancer. J. Natl Cancer Inst. (Bethesda), 88: 1738-1747, 1996.
20. Prentice, R L Aspects of the science of cancer prevention trials lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women Prev Med , 20: 147-157, 1991
21. Blair, S N. Evidence for success of exercise in weight loss and control Ann. Intern. Med , 119: 702-706, 1993.
22. Blair, S. N., Horton, E., Leon, A S., Lee, I M., Drinkwater, B L., Dishman, R. K , Mackey, M., and Kienholz, M. L. Physical activity, nutrition, and chronic disease. Med. Sci. Sports Exerc., 28: 335-349, 1996.
23. Chlebowski, R. T., and Grosvenor, M. The scope of nutrition intervention trials with cancer related endpoints. Cancer (Phila ), 74 (Suppl. 9): 2734-2738, 1994.
24. Rohan, T. E., Fu, W., and Hiller, J E Physical activity and survival from breast cancer Eur. J. Cancer Prev., 4: 419-424, 1995.
25. Lovato, L. C , Hill, K., Herbert, S., Hunninghake, D. B , and Prosbstfield, J L Recruitment for controlled clinical trials literature summary and annotated bibliography. Controlled Clin Trials, 18: 328-352, 1997
26. Fisher, B., Dignam, J., Bryant, J., DeCillis, A , Wickerham, D. L., Wolmark, N., Costantino, J , Redmond, C., Fisher, E. R., Bowman, D. M , Deschenes, L., Dimitrov, N. V., Margolese, R. G., Robidoux, A., Shibata, H , Terz, J., Paterson, A. H., Feldman, M. I., Farrar, W , Evans I., and Lickley, H. L. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors J Natl. Cancer Inst (Bethesda), 88: 1529-1542, 1996
27. Chlebowski, R. T., Blackburn, G. L , Buzzard, I. M., Rose, D. P., Martino, S., Khandekar, J. D., York, R. M., Jeffery, R. W., Elashoff, R. M., and Wynder, E L. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J. Clin. Oncol , 11: 2061-2062, 1993.
28. Rose, D. P , Connolly, J. M , Chlebowski, R T , Buzzard, I. M., and Wynder, E L The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Res. Treat 27: 253-262, 1993.
29. Early Breast Cancer Trialists Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy Lancet, 339: 1-15, 1992